This Episode examine the economic, scientific, and regulatory landscape of the global beauty and skincare industry. They analyze the significant price disparities between luxury, medical-grade, and drugstore products, highlighting how specialized ingredients like peptides and liposomal delivery systems drive up costs. Industry experts explain that premium pricing often reflects heavy investments in clinical research, sustainable sourcing, and Good Manufacturing Practices (GMP). While some reports suggest that affordable alternatives can perform as well as expensive counterparts, others emphasize that high-end brands offer superior potency, stability, and aesthetic experience. Furthermore, the texts provide practical guidance for entrepren ...